Announcements

Announcements

 
 
Paul G. Allen Frontiers Group    [to 25 Apr 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
Press Release
No new digest content identified.
 
 
BMGF – Gates Foundation  [to 25 Apr 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute    [to 25 Apr 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 25 Apr 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 25 Apr 2020]
http://cepi.net/
Latest News
Landmark global collaboration launched to defeat COVID-19 pandemic
Global leaders unite to launch Access to COVID-19 Tool (ACT) accelerator
COVID-19
24 Apr 2020
 
 
Oxford University vaccine against COVID-19 starts clinical tests
Oxford COVID-19 vaccine is the third CEPI-funded programme to enter phase 1 trials
COVID-19
23 Apr 2020
 
 
Saudi Arabia pledges US$150 million to CEPI COVID-19 response
Contribution from Saudi Arabia will help CEPI continue its rapid progress towards developing a vaccine.
COVID-19
21 Apr 2020
 
 
Clinton Health Access Initiative, Inc. (CHAI)  [to 25 Apr 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.
 
 
EDCTP    [to 25 Apr 2020]

http://www.edctp.org/

The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
25 April 2020
World Malaria Day 2020
On World Malaria Day 2020, the fight against malaria is facing stalled progress and a disruptive pandemic while the road to malaria eradication is still long and complex. This World Malaria Day is a call to keep malaria on the…
 
 
Emory Vaccine Center    [to 25 Apr 2020]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 25 Apr 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
News: EU actions to support availability of medicines during COVID-19 pandemic – update #3
Last updated: 24/04/2020
Press release: Reporting suspected side effects of medicines in patients with COVID-19
Last updated: 24/04/2020
News: COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine
Last updated: 23/04/2020
 
 
News: Launch of enhanced monitoring system for availability of medicines used for treating COVID-19
Last updated: 21/04/2020
 
 
News: Update to guidance on regulatory expectations in the context of COVID-19 pandemic
Last updated: 20/04/2020
 
 European Vaccine Initiative  [to 25 Apr 2020]
http://www.euvaccine.eu/news-events
Latest News
World Malaria Day 2020

24 April 2020

EVI remains firmly committed to supporting malaria vaccine development
 
 
FDA [to 25 Apr 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
April 24, 2020 – Coronavirus (COVID-19) Update: Daily Roundup April 24, 2020
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
:: Today, the FDA issued an immediately in effect guidance, Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides during this public health emergency. Increased availability of these devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services rendered by clinical laboratories, hospitals, and other healthcare facilities, and reduce healthcare personnel contact and risk of exposure to SARS-CoV-2.
:: Today, the FDA issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems, that have been reported with their use for the treatment or prevention of COVID-19, for which they are not approved by the FDA. These risks, which are in the drug labels for their approved uses, may be mitigated when health care professionals closely screen and supervise these patients such as in a hospital setting or a clinical trial, as indicated in the Emergency Use Authorization (EUA) for these drugs to treat COVID-19.
:: The FDA and Federal Trade Commission issued a warning letter to a seller of fraudulent COVID-19 products, as part of the agency’s effort to protect consumers. The seller warned, Prefense LLC, offers unapproved and misbranded hand sanitizer products for sale in the U.S. with misleading claims that the products are safe and/or effective for the prevention and treatment of COVID-19. There are currently no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.

:: Diagnostics update to date:
. During the COVID-19 pandemic, the FDA has worked with more than 380 test developers who have said they will be submitting emergency use authorizations (EUA) requests to FDA for tests that detect the virus.
. To date, the FDA has issued 44 individual emergency use authorizations for test kit manufacturers and laboratories. In addition, 19 authorized tests have been added to the EUA letter of authorization for high complexity molecular-based laboratory developed tests (LDTs).
. The FDA has been notified that more than 225 laboratories have begun testing under the policies set forth in our COVID-19 Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Guidance.
. The FDA also continues to keep its COVID-19 Diagnostics FAQ up to date.
 
 
April 24, 2020 – Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
 
 
Fondation Merieux  [to 25 Apr 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 25 Apr 2020]
https://www.gavi.org/
Top Stories
24 April 2020
Gavi and global health actors collaborate to accelerate COVID-19 technologies for all
:: Goal of new global ACT Accelerator is to make COVID-19 diagnostics, therapeutics and vaccines available to everybody that needs them as quickly as possible
:: Alongside Gavi, the other foundational groups within the collaboration are the Bill & Melinda Gates Foundation, the Coalition for Epidemic Preparedness Innovations (CEPI), The Global Fund, UNITAID, the Wellcome Trust and the World Health Organization (WHO)
:: Gavi is helping countries to tackle the pandemic and maintain life-saving immunisation programmes and is ready to contribute to the global response at all stages from development through to production and delivery
 
 
GHIT Fund   [to 25 Apr 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.
 
 
Global Fund  [to 25 Apr 2020]
https://www.theglobalfund.org/en/news/
News & Stories
All the More United in Our Fight Against Malaria
24 April 2020
 
 
Updates
COVID-19 Response: Monitoring Approach and Information Collection
22 April 2020
 
 
Funding Model
COVID-19 Response Mechanism Application Materials
22 April 2020
 
 
Sourcing & Management of Health Products
COVID-19 Response: Health Product Supply Update for Principal Recipients
22 April 2020
 
 
Updates
Youth Council Members
22 April 2020
 
 
Hilleman Laboratories   [to 25 Apr 2020]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 25 Apr 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
Human Vaccines Project Launches Global Initiative to Accelerate the Development of COVID-19 Vaccines for Those Most Vulnerable
Apr 23, 2020
 
 
IAVI  [to 25 Apr 2020]
https://www.iavi.org/newsroom
Press Releases
April 22, 2020
Japan’s Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI Says
NEW YORK – APRIL 22, 2020 – The Government of Japan announced to the World Bank/International Monetary Fund Development Committee on April 17, in partnership with the World Bank, its commitment to contribute $10 million (USD) to IAVI’s COVID-19 vaccine development program.
The announcement follows years of leadership from the Government of Japan, which has provided significant investment in HIV/AIDS vaccine research, in partnership with the World Bank, through it support of IAVI’s work on the vesicular stomatitis virus (VSV) technology; this support has enabled this platform technology to now be applied to a range of pressing global health threats, including COVID-19. The World Bank has been a key partner to IAVI since the organization was founded nearly 25 years ago.
“We are deeply grateful to the Government of Japan and the World Bank for this important commitment to advance COVID-19 vaccine research,” said Mark Feinberg, M.D., Ph.D., IAVI president and CEO…
 
 International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.
 
 
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
ACCESS TO COVID-19 TOOLS (ACT) ACCELERATOR” – IGBA is Joining Forces on Global Collaboration to Overcome COVID-19
(24 April 2020)
GBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, today endorses the commitment and call to action by an initial group of global health actors, private sector partners and other stakeholders, to launch an unprecedented global and time-limited collaboration to accelerate the development, production and equitable global access to new COVID-19 essential health technologies.
 
 
IFFIm
http://www.iffim.org/
Press Releases
No new digest content identified.
 
 IFRC   [to 25 Apr 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Global
“COVID-19 a wake-up call to international community. Urgent need for global solidarity to prevent poverty and food insecurity around the world,” says IFRC President
New York/Geneva, 24 April 2020 – Following his briefings to UN permanent missions this week, Francesco Rocca, President of the International Federation of Red Cross and Red Crescent Societies (IFRC), stressed the importance of communities coming togeth …
 
 
IVAC  [to 25 Apr 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.
 
 
IVI   [to 25 Apr 2020]
http://www.ivi.int/
Selected IVI News & Announcements
LINE and International Vaccine Institute Team Up to Promote the Importance of Vaccination
:: LINE to offer an Official Account to IVI to promote the importance of vaccines and vaccination, as well as feature educational contents starring IVI Goodwill Ambassador Henry Lau
:: LINE FRIENDS’ BT21 character IVI sticker set to be launched in the first half of the year to raise funds for child immunization initiatives
:: Together, LINE and IVI look to establish closer connections with local communities and change people’s lives for the better by communicating on public health topics
April 23, 2020
 
 
JEE Alliance  [to 25 Apr 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 25 Apr 2020]
http://www.msf.org/
Latest [Selected Announcements]
Coronavirus COVID-19 pandemic
Why protecting and supporting staff in care homes during COVID-…
Voices from the Field 24 Apr 2020
 
 
Coronavirus COVID-19 pandemic
Out of view, but not out of mind: MSF’s response to COVID-19 in care h…
Project Update 24 Apr 2020
 
 
Coronavirus COVID-19 pandemic
Vulnerable communities in the US in urgent need of protection from COVI…
Project Update 24 Apr 2020
 
 
Palestine
Like a virus, violence spreads in the West Bank amid COVID-19
Project Update 23 Apr 2020
 
 
DRC Ebola outbreaks
New Ebola cases confirmed in DRC days before expected end of…
Project Update 23 Apr 2020
 
 
Coronavirus COVID-19 pandemic
A race against the pandemic – MSF COVID-19 crisis update
Crisis Update 23 Apr 2020
 
 
DRC Ebola outbreaks
Crisis update – April 2020
Crisis Update 23 Apr 2020
 
 
Coronavirus COVID-19 pandemic
MSF launches a COVID-19 emergency response in Timergara,…
Project Update 22 Apr 2020
 
 
Rohingya refugee crisis
Rohingya refugees left to starve at sea
Voices from the Field 22 Apr 2020
 
 
Coronavirus COVID-19 pandemic
MSF provides care to vulnerable people during COVID-19 response in …[Brazil]
Project Update 22 Apr 2020
 
 
Coronavirus COVID-19 pandemic
Concerns mount over COVID-19 response in northeast Syria
Press Release 22 Apr 2020
 
 
Burkina Faso
COVID-19 will worsen access to healthcare in Burkina Faso
Project Update 21 Apr 2020
 
 
Coronavirus COVID-19 pandemic
MSF provides support to hospitals and sites in response to COVID-19 …[Sudan]
Project Update 20 Apr 2020
 
 
National Vaccine Program Office – U.S. HHS  [to 25 Apr 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)
 
 
NIH  [to 25 Apr 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
NIAID strategic plan details COVID-19 research priorities
April 23, 2020 — Urgent public health measures are needed to control the spread of the novel coronavirus.
[See COVID-19 R&D above for detail]
 
 
Expert U.S. panel develops NIH treatment guidelines for COVID-19
April 21, 2020 — “Living document” expected to be updated often as new clinical data accrue.
A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19). These guidelines, intended for healthcare providers, are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapidly evolving pandemic. The guidelines are posted online (covid19treatmentguidelines.nih.gov) and will be updated often as new data are published in peer-reviewed scientific literature and other authoritative information emerges…
 
 
PATH  [to 25 Apr 2020]
https://www.path.org/media-center/
Selected Announcements
PATH and partners develop and market environmental surveillance tool for polio eradication
April 23, 2020 by PATH
Partnership ensures global access to an improved filtration system designed to detect poliovirus — and potentially COVID-19
Seattle, Washington, USA, April 27, 2020 — This month, PATH, the University of Washington (UW), and Scientific Methods Inc. (SMI), a subsidiary of the Institute for Environmental Health Laboratories, announced the commercial launch of the bag-mediated filtration system (BMFS) to support environmental surveillance of poliovirus (PV). The innovative new system is validated for the sensitive capture and detection of PV, and the use of the system for other viruses is expected to be equally effective. The tool strengthens environmental surveillance efforts in support of the global eradication of polio and potentially in the response to the COVID-19 pandemic as the filter can capture both viruses at the same time from a sample…
 
 
Sabin Vaccine Institute  [to 25 Apr 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
 
 UNAIDS [to 25 Apr 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
24 April 2020
COVID-19 responses must uphold and protect the human rights of sex workers
 
 
21 April 2020
Sex workers adapting to COVID-19
 
 
20 April 2020
Wide differences in incidence–prevalence ratio by region
 
 UNICEF  [to 25 Apr 2020]
https://www.unicef.org/media/press-releases
Press release
COVID-19: UNICEF is scaling up delivery of health and hygiene supplies across Latin America and Caribbean
25/04/2020
 
 
Press release
Over 13 million children did not receive any vaccines at all even before COVID-19 disrupted global immunization – UNICEF
Mass measles immunization campaigns suspended in 25 largely high-burden countries due to pandemic
24/04/2020
 
 
Press release
Thousands of Pacific Island children at risk in the aftermath of Tropical Cyclone Harold
24/04/2020
 
 
Press release
World’s most defiantly joyful song rereleased by UNICEF
Mama Africa’s smash-hit “Pata Pata” rerecorded by Angelique Kidjo to to spread information and hope in a time of Coronavirus
22/04/2020
 
 
Press release
UNICEF supports the Government of the Democratic Republic of the Congo in continuing immunization in North Kivu during COVID-19
21/04/2020
 
 
Statement
UN agencies issue urgent call to fund the global emergency supply system to fight COVID-19
21/04/2020
 
 
Press release
Global Report on Food Crises reveals scope of food crises as COVID-19 poses new risks to vulnerable countries
Annual report on acute food insecurity and malnutrition published today
21/04/2020
 
 
Statement
As COVID-19 pandemic continues, forcibly displaced children need more support than ever
Joint statement by Henrietta Fore, UNICEF Executive Director, and Filippo Grandi, UN High Commissioner for Refugees
20/04/2020
 
 
Press release
UNICEF and Microsoft launch global learning platform to help address COVID-19 education crisis
As school closures in more than 190 countries force over 1.57 billion students from their classrooms, the Learning Passport aims to keep children learning
20/04/2020
 
 
Unitaid  [to 25 Apr 2020]
https://unitaid.org/#en
Featured News
24 April 2020
Unitaid responds to global call to action partnership for COVID-19
 
 
24 April 2020
Unitaid reaffirms its commitment to confront malaria in the context of COVID-19
 
 
Vaccination Acceptance Research Network (VARN)  [to 25 Apr 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.
 
 
Vaccine Confidence Project  [to 25 Apr 2020]
http://www.vaccineconfidence.org/
Latest News & Archive
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 25 Apr 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
April 2020
Announcements: Updated and new info, essay contest, coronavirus Q&A webpage and archived webinar
 
 
Wellcome Trust  [to 25 Apr 2020]
https://wellcome.ac.uk/news
Opinion | 24 April 2020
Why the world needs $8 billion now to get us to COVID-Zero
Jeremy Farrar, Director Wellcome
Only when we have tools to detect, treat and prevent coronavirus disease everywhere, will we be able to stop the pandemic. Developing these tools requires new global partnerships and cooperation.
[See COVID-19 Perspectives above for detail]
 
 
Opinion | 24 April 2020
Developing a vaccine for COVID-19: what can we learn from past outbreaks?
by Charlie Weller
 
 
Explainer | 22 April 2020
How can we develop a COVID-19 vaccine quickly?
A vaccine would be an incredibly powerful tool to slow down the coronavirus pandemic. This is how vaccine development needs to change to get to a COVID-19 vaccine.
 
 
The Wistar Institute   [to 25 Apr 2020]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.
 
 
WFPHA: World Federation of Public Health Associations  [to 25 Apr 2020]
https://www.wfpha.org/
Latest News
WFPHA Press Release: Endorse The InterAction Council’s Global Responsibilities and an Emergency Framework for Countries and Communities
Friday, 24 April 2020
The World Federation of Public Health Associations (WFPHA) is pleased to endorse the InterAction Council of former heads of state and government’s Global Responsibilities and an Emergency Framework for Countries and Communities.

The InterAction Council’s framework aligns well with the WFPHA’s guiding principles of solidarity, social justice, human rights, equity, evidenced-informed policy and practice, and the need to address the underlying socio-economic, commercial, human rights-related and political determinants of health. The WFPHA’s Global Charter for the Public’s Health aligns well with and supports the Framework’s elements. Besides calling for strengthening the primary elements of public health (disease and injury prevention, health promotion and health protection) and health system operations and measures, the Framework recommends an all-of-society approach across all sectors for future pandemic and emergency responses.

Please read full document here.
 
 
World Organisation for Animal Health (OIE)   [to 25 Apr 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
24/04/20
Responding to the COVID-19 crisis: the contribution of the veterinary profession
In the face of the current pandemic, solidarity is key. On the occasion of World Veterinary Day, which will be held on April 25th, the OIE pays tribute to the great effort made by the veterinary profession to support the human health sector, from research to human sample testing, as well as provision of human and material resources.
…This pandemic awakens the need for longstanding and sustainable One Health collaboration which can take many forms.
Beyond collaborative research, the animal health sector, and in particular, Veterinary Services, contribute in various ways towards building a common response to the pandemic. In many countries, veterinarians have shown their commitment to support the work of human health authorities. Veterinary laboratories have used their experience and expertise in high throughput testing capacity of infectious diseases to engage in activities such as surveillance screening, by testing human samples, thereby supporting the diagnostic capacity of human health services. Some veterinary clinics have been donating essential materials such as personal protective equipment and ventilators. Veterinary professionals have also been volunteering in hospitals and laboratories when human resources were not sufficient. In some countries, veterinary epidemiologists have been supporting their counterparts in the public health response to track the disease in humans and to support the development of effective public health interventions…

::::::
 
 
ARM [Alliance for Regenerative Medicine]  [to 25 Apr 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.
 
 
BIO    [to 25 Apr 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 25 Apr 2020]
http://www.dcvmn.org/
News
COVID 19 Resources
 
 
IFPMA   [to 25 Apr 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
Published on: 24 April 2020
[See COVID-19 R&D above for detail]
 
 
IFPMA Backgrounder – COVID-19
24 April 2020
[See COVID-19 R&D above for detail]
 
 
 
PhRMA    [to 25 Apr 2020]
http://www.phrma.org/
Selected Press Releases, Statements
New report shows nearly 260 vaccines in development, including dozens for COVID-19
Andrew Powaleny   |     April 23, 2020
[See COVID-19 R&D above for detail]